MDGL Madrigal Pharmaceuticals, Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
16:17
Oct 08
psyduckcapital
Opened small MDGL starter position
Opened a small under-1% starter in MDGL as a quality biotech popular with funds that got sold indiscriminately, with near-term catalyst support and clear inherent value; plans to double up lower.
MDGL Madrigal Pharmaceuticals, Inc. Long 1ST Position: Opened —
00:07
Jul 27
seedy19tron
Buy MDGL as a second-tier derisked/M&A candidate within the speaker's biotech conviction list. Stock list
Buy MDGL as a second-tier derisked/M&A candidate within the speaker's biotech conviction list; lower conviction than top-tier names but still recommended for capital deployment.
MDGL Madrigal Pharmaceuticals, Inc. Long 1ST — —

About MDGL Investor Commentary

Across the available history and selected sources, Buzzberg tracks MDGL (Madrigal Pharmaceuticals, Inc.) across 3 sources: 2 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 12% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 17 total trade ideas tracked. Past 7 days, before deduplication: 2 other directions. Latest voices: psyduckcapital, seedy19tron.